| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 23 | 2025 | 164 | 8.200 |
Why?
|
| Macrophages | 21 | 2023 | 515 | 4.330 |
Why?
|
| Cholesterol | 11 | 2024 | 230 | 3.560 |
Why?
|
| Hyperlipidemias | 5 | 2025 | 47 | 2.450 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2023 | 180 | 1.270 |
Why?
|
| Interleukin-10 | 4 | 2014 | 86 | 1.230 |
Why?
|
| Aorta | 8 | 2018 | 197 | 1.120 |
Why?
|
| Interleukin-1 | 3 | 2017 | 39 | 1.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2025 | 379 | 1.100 |
Why?
|
| Cardiovascular Diseases | 5 | 2023 | 729 | 1.090 |
Why?
|
| Mice, Inbred C57BL | 21 | 2025 | 1804 | 1.090 |
Why?
|
| Animals | 45 | 2025 | 16695 | 1.050 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 142 | 1.040 |
Why?
|
| Hypercholesterolemia | 1 | 2025 | 42 | 0.900 |
Why?
|
| Ventricular Remodeling | 2 | 2023 | 58 | 0.900 |
Why?
|
| Aortic Diseases | 2 | 2014 | 34 | 0.890 |
Why?
|
| Cells, Cultured | 13 | 2020 | 1617 | 0.870 |
Why?
|
| Myocardium | 4 | 2023 | 251 | 0.860 |
Why?
|
| Neutrophils | 1 | 2025 | 141 | 0.850 |
Why?
|
| Inflammation Mediators | 5 | 2021 | 138 | 0.840 |
Why?
|
| Mice | 29 | 2025 | 6490 | 0.810 |
Why?
|
| Mice, Knockout | 12 | 2021 | 1010 | 0.780 |
Why?
|
| RNA | 4 | 2025 | 266 | 0.780 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 242 | 0.770 |
Why?
|
| Hair | 3 | 2023 | 38 | 0.760 |
Why?
|
| Monocytes | 4 | 2023 | 275 | 0.710 |
Why?
|
| Lipid Metabolism | 4 | 2024 | 140 | 0.700 |
Why?
|
| Receptors, LDL | 7 | 2016 | 40 | 0.670 |
Why?
|
| Aorta, Thoracic | 2 | 2021 | 31 | 0.660 |
Why?
|
| Plant Extracts | 3 | 2020 | 303 | 0.650 |
Why?
|
| Cytokines | 5 | 2020 | 661 | 0.610 |
Why?
|
| Endothelial Cells | 3 | 2020 | 324 | 0.600 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 92 | 0.590 |
Why?
|
| Signal Transduction | 9 | 2025 | 2111 | 0.570 |
Why?
|
| Immunity, Innate | 1 | 2019 | 168 | 0.560 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2021 | 97 | 0.560 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2017 | 19 | 0.560 |
Why?
|
| Inflammation | 8 | 2024 | 729 | 0.550 |
Why?
|
| Humans | 33 | 2025 | 42163 | 0.540 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1420 | 0.540 |
Why?
|
| Apolipoproteins E | 3 | 2017 | 137 | 0.540 |
Why?
|
| Geranium | 1 | 2017 | 1 | 0.530 |
Why?
|
| Dermis | 1 | 2017 | 9 | 0.530 |
Why?
|
| Leukocytes | 2 | 2014 | 79 | 0.490 |
Why?
|
| Imidazoles | 3 | 2021 | 138 | 0.480 |
Why?
|
| Heart | 3 | 2023 | 181 | 0.470 |
Why?
|
| Foam Cells | 3 | 2013 | 16 | 0.460 |
Why?
|
| Cell Lineage | 2 | 2015 | 104 | 0.460 |
Why?
|
| Cell Differentiation | 2 | 2015 | 633 | 0.450 |
Why?
|
| HIV Infections | 4 | 2023 | 2535 | 0.440 |
Why?
|
| Hair Follicle | 3 | 2020 | 10 | 0.440 |
Why?
|
| Male | 21 | 2025 | 22779 | 0.440 |
Why?
|
| Acetylglucosamine | 1 | 2013 | 8 | 0.410 |
Why?
|
| Trisaccharides | 1 | 2013 | 11 | 0.410 |
Why?
|
| Lipoylation | 1 | 2013 | 17 | 0.400 |
Why?
|
| Arteriosclerosis | 5 | 2003 | 42 | 0.390 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2012 | 10 | 0.390 |
Why?
|
| Valine | 1 | 2012 | 29 | 0.380 |
Why?
|
| Leucine | 1 | 2012 | 30 | 0.380 |
Why?
|
| MicroRNAs | 2 | 2016 | 501 | 0.380 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 58 | 0.380 |
Why?
|
| Crystallization | 2 | 2024 | 88 | 0.370 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 1554 | 0.370 |
Why?
|
| Thiophenes | 2 | 2021 | 30 | 0.360 |
Why?
|
| Selenoproteins | 1 | 2013 | 146 | 0.350 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 457 | 0.340 |
Why?
|
| Sulfonamides | 2 | 2021 | 88 | 0.340 |
Why?
|
| Time Factors | 4 | 2016 | 1848 | 0.330 |
Why?
|
| Endothelium, Vascular | 3 | 2021 | 261 | 0.320 |
Why?
|
| Selectins | 1 | 2008 | 3 | 0.300 |
Why?
|
| Lipoproteins, LDL | 3 | 2017 | 66 | 0.300 |
Why?
|
| Fucosyltransferases | 1 | 2008 | 9 | 0.300 |
Why?
|
| Myocardial Ischemia | 2 | 2021 | 82 | 0.300 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 35 | 0.290 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 88 | 0.280 |
Why?
|
| Chemotaxis | 1 | 2008 | 66 | 0.280 |
Why?
|
| Up-Regulation | 2 | 2009 | 534 | 0.270 |
Why?
|
| Flow Cytometry | 5 | 2020 | 411 | 0.250 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 36 | 0.250 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2006 | 21 | 0.250 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2025 | 22 | 0.240 |
Why?
|
| Phenotype | 3 | 2016 | 774 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 100 | 0.230 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2025 | 51 | 0.230 |
Why?
|
| Receptor, Angiotensin, Type 2 | 2 | 2021 | 10 | 0.220 |
Why?
|
| RNA, Messenger | 4 | 2017 | 1265 | 0.220 |
Why?
|
| Cell Line | 4 | 2013 | 1416 | 0.220 |
Why?
|
| Extracellular Fluid | 2 | 2014 | 15 | 0.220 |
Why?
|
| Ribonucleases | 2 | 2014 | 32 | 0.220 |
Why?
|
| Apoptosis | 4 | 2017 | 1541 | 0.220 |
Why?
|
| Immunohistochemistry | 4 | 2019 | 928 | 0.210 |
Why?
|
| COS Cells | 2 | 2014 | 67 | 0.210 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 658 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2025 | 253 | 0.200 |
Why?
|
| Cell Movement | 2 | 2017 | 640 | 0.200 |
Why?
|
| Regeneration | 1 | 2023 | 29 | 0.200 |
Why?
|
| Wound Healing | 1 | 2023 | 82 | 0.190 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2002 | 45 | 0.190 |
Why?
|
| Aorta, Abdominal | 1 | 2021 | 17 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 1066 | 0.180 |
Why?
|
| Complement System Proteins | 1 | 2021 | 25 | 0.180 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2021 | 13 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2020 | 268 | 0.180 |
Why?
|
| Mice, Mutant Strains | 4 | 2008 | 85 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2021 | 33 | 0.170 |
Why?
|
| Salvia | 1 | 2020 | 10 | 0.170 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2021 | 32 | 0.170 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2021 | 47 | 0.170 |
Why?
|
| Stem Cell Factor | 2 | 2017 | 7 | 0.170 |
Why?
|
| Dyslipidemias | 1 | 2021 | 48 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 88 | 0.160 |
Why?
|
| Female | 7 | 2025 | 24018 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 255 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2020 | 80 | 0.160 |
Why?
|
| Mast Cells | 2 | 2017 | 83 | 0.160 |
Why?
|
| Lysosomes | 1 | 2020 | 88 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 184 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2019 | 10 | 0.160 |
Why?
|
| Pregnancy | 1 | 2025 | 1737 | 0.150 |
Why?
|
| Carotid Arteries | 2 | 2017 | 35 | 0.150 |
Why?
|
| E-Selectin | 1 | 2018 | 23 | 0.150 |
Why?
|
| Sinus of Valsalva | 1 | 2017 | 3 | 0.140 |
Why?
|
| Rolipram | 1 | 2017 | 2 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2017 | 12 | 0.140 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2017 | 5 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 2 | 2021 | 137 | 0.140 |
Why?
|
| Smad3 Protein | 1 | 2017 | 12 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2017 | 10 | 0.140 |
Why?
|
| Homeostasis | 2 | 2020 | 193 | 0.140 |
Why?
|
| Interleukin-18 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Organ Specificity | 1 | 2017 | 141 | 0.130 |
Why?
|
| Poaceae | 1 | 2017 | 14 | 0.130 |
Why?
|
| Flowers | 1 | 2017 | 20 | 0.130 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 34 | 0.130 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 7 | 0.130 |
Why?
|
| Liposomes | 1 | 2017 | 130 | 0.130 |
Why?
|
| Cardiology | 1 | 2016 | 19 | 0.130 |
Why?
|
| Elastin | 1 | 2016 | 40 | 0.130 |
Why?
|
| Necrosis | 1 | 2016 | 54 | 0.130 |
Why?
|
| Lipoproteins | 2 | 2009 | 68 | 0.120 |
Why?
|
| Lipids | 3 | 2009 | 256 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 143 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 40 | 0.110 |
Why?
|
| Apolipoprotein A-I | 1 | 2014 | 24 | 0.110 |
Why?
|
| HIV-1 | 1 | 2020 | 747 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 683 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 81 | 0.110 |
Why?
|
| Risk Factors | 1 | 2023 | 3942 | 0.110 |
Why?
|
| Interleukins | 1 | 2013 | 37 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 164 | 0.100 |
Why?
|
| Transfection | 1 | 2014 | 526 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 170 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 649 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 727 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2014 | 452 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Inositol Phosphates | 1 | 2012 | 8 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 189 | 0.090 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 223 | 0.090 |
Why?
|
| Cyclic AMP | 1 | 2012 | 135 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 503 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 491 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 641 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 21 | 0.080 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2021 | 95 | 0.080 |
Why?
|
| Ligands | 2 | 2008 | 387 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 122 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 3 | 2005 | 18 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2008 | 6 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 83 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2009 | 226 | 0.070 |
Why?
|
| Chemokine CCL2 | 2 | 2006 | 95 | 0.070 |
Why?
|
| Chimera | 1 | 2006 | 18 | 0.060 |
Why?
|
| Chemokine CXCL1 | 1 | 2006 | 18 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2005 | 6 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2003 | 318 | 0.050 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 59 | 0.050 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2003 | 7 | 0.050 |
Why?
|
| Bystander Effect | 1 | 2023 | 15 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2025 | 173 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 66 | 0.050 |
Why?
|
| Obesity | 2 | 2021 | 1131 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2002 | 39 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 63 | 0.050 |
Why?
|
| Testis | 1 | 2023 | 203 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 166 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2021 | 51 | 0.050 |
Why?
|
| Actins | 1 | 2022 | 162 | 0.050 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2021 | 11 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 99 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2021 | 18 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 244 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 71 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 44 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 97 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2021 | 74 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 221 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 178 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2003 | 267 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 37 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2021 | 74 | 0.040 |
Why?
|
| Liquid Crystals | 1 | 2020 | 5 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 357 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 599 | 0.040 |
Why?
|
| Psoriasis | 1 | 2020 | 19 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 548 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 385 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 297 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2018 | 17 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2003 | 722 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 28 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2018 | 64 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 381 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 1729 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 84 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1112 | 0.030 |
Why?
|
| Substance P | 1 | 2017 | 26 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 229 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 140 | 0.030 |
Why?
|
| Tibia | 1 | 2016 | 26 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 98 | 0.030 |
Why?
|
| Femur | 1 | 2016 | 46 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 75 | 0.030 |
Why?
|
| Skin | 1 | 2017 | 185 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 214 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 30 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 188 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 324 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 11819 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3077 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 973 | 0.030 |
Why?
|
| Endostatins | 1 | 2013 | 5 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2013 | 7 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 7 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2485 | 0.030 |
Why?
|
| Stem Cells | 1 | 2015 | 151 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 12 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 475 | 0.030 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2015 | 181 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2013 | 74 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 278 | 0.030 |
Why?
|
| Antioxidants | 1 | 2017 | 439 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 303 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 13458 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 78 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2013 | 69 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 990 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 7982 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 47 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Chromatography | 1 | 2003 | 17 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 51 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2003 | 1 | 0.010 |
Why?
|
| Peptide Library | 1 | 2003 | 27 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 68 | 0.010 |
Why?
|
| Perforin | 1 | 2002 | 11 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2002 | 6 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 692 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 279 | 0.010 |
Why?
|
| Vesicular Transport Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 884 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 201 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 1188 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 661 | 0.010 |
Why?
|
| Lung | 1 | 2003 | 484 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 557 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 383 | 0.010 |
Why?
|